Anzupgo 2 % Topical Cream
- RxCUI
- 2721172
- RxNorm name
- Anzupgo 2 % Topical Cream
- Display name
- Anzupgo 2 % Topical Cream
- Full name
- Anzupgo 2 % Topical Cream
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anzupgo | DELGOCITINIB | LEO Pharma, Inc | a59bf36e-6f04-4b47-b385-8040c95f040c | 2026-07-10 | Warnings, Adverse reactions | 2721172 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a59bf36e-6f04-4b47-b385-8040c95f040c | Anzupgo 2 % Topical Cream | PSN | 4 | These highlights do not include all the information needed to use ANZUPGO ® safely and effectively. See full prescribing information for ANZUPGO ® . ANZUPGO ® (delgocitinib) cream, for topical use Initial U.S. Approval: 2025 | 20250728 |
| a59bf36e-6f04-4b47-b385-8040c95f040c | delgocitinib 20 MG/ML Topical Cream [Anzupgo] | SBD | 4 | These highlights do not include all the information needed to use ANZUPGO ® safely and effectively. See full prescribing information for ANZUPGO ® . ANZUPGO ® (delgocitinib) cream, for topical use Initial U.S. Approval: 2025 | 20250728 |
| a59bf36e-6f04-4b47-b385-8040c95f040c | Anzupgo 2 % Topical Cream | SY | 4 | These highlights do not include all the information needed to use ANZUPGO ® safely and effectively. See full prescribing information for ANZUPGO ® . ANZUPGO ® (delgocitinib) cream, for topical use Initial U.S. Approval: 2025 | 20250728 |